Navigation Links
Beta Blockers May Slow Spread of Breast Cancer
Date:3/26/2010

Small study found they boost survival, but results are preliminary

FRIDAY, March 26 (HealthDay News) -- Treatment with blood pressure-lowering drugs known as beta blockers appears to help reduce the spread of breast cancer in women, a team of British and German researchers report.

The drugs are believed to work by preventing stress hormones from stimulating cancer cells. "Beta- blocker drugs compete with stress hormones and bind to the same target receptors [on a cellular level], but unlike stress hormones, do not activate cancer cells," said Dr. Des Powe, a senior healthcare research scientist at Queen's Medical Centre, Nottingham University Hospital NHS Trust, in Nottingham, England.

Powe is due to present the findings Friday at the annual European Breast Cancer Conference in Barcelona, Spain.

Powe and his colleagues from the U.K. and Germany evaluated 466 cancer patients: 92 had received blood pressure-lowering medications and 43 of those 92, or nearly half, were on beta blockers at the time of their breast cancer diagnosis.

Those on beta blockers had a substantial reduction in the formation of distant cancers, or metastases, and of local recurrence. They had a 71 percent reduced risk of death from breast cancer during the study compared to those who were either taking other blood pressure drugs or weren't on any blood pressure medications. Those on beta blockers also had a 57 percent reduced risk of getting a secondary cancer.

"Our study was performed retrospectively, using patient notes [from women] that had received treatment in the late 1980s and 1990s," Powe said.

Other experts called the results interesting, but preliminary. "The concept of controlling tumor growth by preventing a stress or inflammatory response is not novel," said Dr. Cathie Chung, a medical oncologist and an assistant professor of oncology at the City of Hope National Medical Center in Duarte, Calif.

For instance, other research has found that women with breast cancer who regularly take aspirin, which is an anti-inflammatory, may have a decreased risk of recurrence.

"I think this study is interesting, but very far from being conclusive," said Chung. It's not known, she said, whether there is a true association or whether it may be due to chance or another factor.

"There is more work to be done before you can say whether this relationship is meaningful and will hold up," agreed Dr. Len Lichtenfeld, deputy chief medical officer for the American Cancer Society.

As in other retrospective studies, he said, more research is needed to verify the potential link.

"There are many other factors that come into play that could explain what happened," Lichtenfeld said. "What if the women who take the beta blockers are more attuned to their health and they may be taking better care of themselves?"

Like Chung, he agreed the proposed association is not far-fetched, just that more study is needed. Previous research, Lichtenfeld said, has found a reduced rate of skin cancer among men who take another type of blood pressure-lowering drug.

Powe said he plans to do another study to validate the results.

More information

To learn more about inflammation and cancer, visit the U.S. National Cancer Institute.



SOURCES: Des Powe, Ph.D., senior healthcare research scientist, Queen's Medical Centre, Nottingham University Hospital NHS Trust, Nottingham, U.K.; Len Lichtenfeld, M.D., Ph.D., deputy chief medical officer, American Cancer Society, Atlanta; Cathie Chung, M.D., Ph.D., medical oncologist and assistant professor, oncology, City of Hope National Medical Center, Duarte, Calif.; March 26, 2010, presentation, European Breast Cancer Conference, Barcelona


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Beta-blockers help reduce metastasis and improve survival in breast cancer patients
2. Widespread Public Defibrillators May Save Lives
3. Flexible Floor-Cleaning Routine Helps School Prevent Spread of Infection
4. H1N1 Flu Spreads Slower Than Seasonal Flu: Study
5. Proteins May Predict Spread of Colon Cancer
6. Freezing breast tumors helps stop cancer’s spread in mice, U-M study finds
7. Mayo Clinic researchers find oncogene is important in pancreatic cancer growth and spread
8. UCR researcher identifies mechanism malaria parasite uses to spread in red blood cells
9. Fans Spread the Love on Target Facebook Page and Help Donate $1 Million to Five Charities
10. Family's Fight to Save Child Spreads Hope Around Globe
11. Researcher to track spread of disease, malware and power outages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
(Date:10/12/2017)... Miramar, FL (PRWEB) , ... October 12, 2017 ... ... is presenting the latest in wound care advancements to physician colleagues, skilled nursing ... lecture is titled, "Navigating the Treacherous Waters of Wound Care." , "At many ...
(Date:10/12/2017)... CHICAGO (PRWEB) , ... October ... ... innovator in life sciences content management, presents its enhanced Pepper Flow promotional ... Oct. 16 -18, 2017. Pepper Flow’s increased insight-driven capabilities help marketers streamline ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , the ... chains, has published the first annual edition of its Global CSR Risk ... 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly ... ... Performance Index ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
Breaking Medicine Technology: